更多详细新闻请浏览新京报网 www.bjnews.com.cn
The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
。业内人士推荐爱思助手下载最新版本作为进阶阅读
Go to technology
However, the platform said it was now developing "more verification options" for users that would not require facial or ID scans. One such option in development is credit card verification.